@Kalenn wouldn't quote a per share calculation based on 100% of the project. I'm more interested in his dilution assumptions.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025